Von Willebrand disease in the Netherlands: The WiN study;De ziekte van von Willebrand in Nederland: De WiN-studie

Nederlands Tijdschrift voor Geneeskunde

Volumn 158, Issue 19, 2014, Pages

  Sanders, Yvonne V ^a   De Wee, Eva M ^a   Meijer, Karina ^c   Eikenboom, Jeroen ^d   Van Der Bom, Johanna G ^d   Fijnvandraat, C J ^e   Laros Van Gorkom, Britta A P ^f   Cnossen, Marjon H ^b   Mauser Bunschoten, Evelien P ^g   Leebeek, Frank W G ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

^f RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^g UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

VON WILLEBRAND FACTOR;

ARTERY THROMBOSIS; ARTICLE; BLEEDING; BRAIN INFARCTION; DISEASE SEVERITY; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENORRHAGIA; NETHERLANDS; QUALITY OF LIFE; SEX DIFFERENCE; VON WILLEBRAND DISEASE; CLASSIFICATION; GENETICS; METABOLISM; POSTPARTUM HEMORRHAGE; STROKE; VON WILLEBRAND DISEASES;

FEMALE; HUMANS; MALE; MENORRHAGIA; NETHERLANDS; POSTPARTUM HEMORRHAGE; STROKE; VON WILLEBRAND DISEASES; VON WILLEBRAND FACTOR;

EID: 84901722138     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand's disease. Blood. 1987;69:454-9. (Pubitemid 17022013)
2. Sadler JE, Mannucci PM, Berntorp E, et al. Impact, diagnosis and treatment of von Willebrand disease. Thromb Haemost. 2000;84:160-74. (Pubitemid 30601459)
3. Tosetto A, Rodeghiero F, Castaman G, et al. A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD). J Thromb Haemost. 2006;4:766-73.
4. Rodeghiero F, Tosetto A, Abshire T, et al. ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. J Thromb Haemost. 2010;8:2063-5.
5. Biss TT, Blanchette VS, Clark DS, et al. Quantitation of bleeding symptoms in children with von Willebrand disease: use of a standardized pediatric bleeding questionnaire. J Thromb Haemost. 2010;8:950-6.
6. Sadler JE, Budde U, Eikenboom JC, et al. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. J Thromb Haemost. 2006;4:2103-14. (Pubitemid 44403432)
7. Leebeek FWG, Mauser-Bunschoten EP (red). Nederlandse Vereniging van Hemofiliebehandelaars. Richtlijn diagnostiek en behandeling van hemofilie en aanverwante hemostasestoornisssen. Alphen aan de Rijn: Van Zuiden Communications BV; 2009:13-23.
8. Verhezen PWM, Beckers EAM, Henskens YMC. Von-willebrandfactor en de ziekte van von Willebrand. Ned Tijdschr Geneeskd. 2014;158:A6885.
9. Mannucci PM, Ruggeri ZM, Pareti FI, Capitanio A. 1-Deamino-8-darginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrands' diseases. Lancet. 1977;1(8017):869-72. (Pubitemid 8079684)
10. Kaufmann JE, Vischer UM. Cellular mechanisms of the hemostatic effects of desmopressin (DDAVP). J Thromb Haemost. 2003;1:682-9.
11. Holmberg L, Nilsson IM, Borge L, Gunnarsson M, Sjorin E. Platelet aggregation induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in Type IIB von Willebrand's disease. N Engl J Med. 1983;309:816-21. (Pubitemid 13005034)
12. Federici AB. Clinical diagnosis of von Willebrand disease. Haemophilia. 2004;10(Suppl 4):169-76. (Pubitemid 40045438)
13. De Wee EM, Sanders YV, Mauser-Bunschoten EP, et al. Determinants of bleeding phenotype in adult patients with moderate or severe von Willebrand disease. Thromb Haemost. 2012;108:683-92.
14. De Wee EM, Knol HM, Mauser-Bunschoten EP, et al. Gynaecological and obstetric bleeding in moderate and severe von Willebrand disease. Thromb Haemost. 2011;106:885-92.
15. Knol HM, Bogchelman DH, Kluin-Nelemans HC, van der Zee AG, van der Meer J, Meijer K. Routine evaluation and treatment of unexplained menorrhagia: do we consider haemostatic disorders? Eur J Obstet Gynecol Reprod Biol. 2010;152:191-4.
16. Jansen AJ, van Rhenen DJ, Steegers EA, Duvekot JJ. Postpartum hemorrhage and transfusion of blood and blood components. Obstet Gynecol Surv. 2005;60:663-71. (Pubitemid 41368533)
17. De Wee EM, Klaij K, Eikenboom HC, van der Bom JG, Fijnvandraat K, Laros-van Gorkom BA, et al. Effect of fibrinolysis on bleeding phenotype in moderate and severe von Willebrand disease. Haemophilia. 2012;18:444-51.
18. De Wee EM, Fijnvandraat K, de Goede-Bolder A, et al. Impact of von Willebrand disease on health-related quality of life in a pediatric population. J Thromb Haemost. 2011;9:502-9.
19. De Wee EM, Mauser-Bunschoten EP, van der Bom JG, et al. Health-related quality of life among adult patients with moderate and severe von Willebrand disease. J Thromb Haemost. 2010;8:1492-9.
20. Miners AH, Sabin CA, Tolley KH, Jenkinson C, Kind P, Lee CA. Assessing health-related quality-of-life in individuals with haemophilia. Haemophilia. 1999;5:378-85. (Pubitemid 30003764)
21. Van Schie MC, van Loon JE, de Maat MP, Leebeek FW. Genetic determinants of von Willebrand factor levels and activity in relation to the risk of cardiovascular disease: a review. J Thromb Haemost. 2011;9:899-908.
22. Tuinenburg A, Mauser-Bunschoten EP, Verhaar MC, Biesma DH, Schutgens RE. Cardiovascular disease in patients with hemophilia. J Thromb Haemost. 2009;7:247-54.
23. Sanders YV, Eikenboom J, de Wee EM, et al. Reduced prevalence of arterial thrombosis in von Willebrand disease. J Thromb Haemost. 2013;11:845-54.